Compound ID | 616
Class: Macrolide
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Sphingomyelin phosphodiesterase inhibitors; low activity against bacteriodes and other anaerobes |
| Institute where first reported: | Daiichi Sankyo Pharmaceutical, Japan |
| Year first mentioned: | 1986 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| Reason Dropped: | Very low potency to tested bacteria |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/10019526 |
| Guide to Pharmacology: | Macquarimicin A |
| Citations: |
|